SCHEMBL10154294

SCHEMBL10154294

CC(C)Oc1ccc(-c2cc(F)c(F)c(F)c2)c2c1-c1c(OC(C)C)ccc(-c3cc(F)c(F)c(F)c3)c1CCC2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
TSHR P16473 2/20 0.34
HSD17B10 Q99714 2/20 0.34
ALOX5AP P20292 2/20 0.34
FEN1 P39748 2/20 0.34
POLB P06746 1/20 0.34
FFAR4 Q5NUL3 7/20 0.34
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
S1PR5 Q9H228 1/20 0.32
NAAA Q02083 1/20 0.31
NR4A2 P43354 1/20 0.31
DHODH Q02127 1/20 0.31
PTGS2 P35354 2/20 0.31
KCNH2 Q12809 1/20 0.30
TMEM97 Q5BJF2 1/20 0.30
SIGMAR1 Q99720 1/20 0.30
GIPR P48546 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10120028 0.85 PTGS2 (0.41) KDM4EALDH1A1HPGDDHODHPTGS2
SCHEMBL2608091 0.77 PTGS2 (0.39) PTGS2
SCHEMBL19644908 0.63 ALOX5AP (0.37) ALOX5APFEN1FFAR4S1PR1S1PR3
SCHEMBL548087 0.63 CD274 (0.46) PTGS2
SCHEMBL26769952 0.63 CSNK2A1 (0.39) ALDH1A1TSHRFFAR4KCNH2TMEM97
SCHEMBL25835370 0.60 FFAR4 (0.37) ALDH1A1POLBFFAR4KCNH2TMEM97
SCHEMBL11916146 0.60 KCNQ3 (0.33) ALDH1A1ALOX5APFEN1
SCHEMBL23341322 0.60 S1PR1 (0.41) ALDH1A1HPGDS1PR1S1PR3KCNH2
SCHEMBL2608090 0.60 PTGS2 (0.38) ALOX5APFEN1POLBPTGS2
SCHEMBL20032260 0.60 NAAA (0.41) ALOX5APFEN1FFAR4S1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110680-B2 Optically active quaternary ammonium salt having axial asymmetry, and method for producing alpha-amino acid and derivative thereof by using the same NAGASE & CO., LTD. (JP) 2012-02-07 US disclosed
US-20100029935-A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME NAGASE & CO., LTD. (JP) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029935-A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME AADAT, BCAT1, BCAT2 KDM4E 2229/4885ALDH1A1 3013/4885HPGD 4801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.